Shire PLC Company Profile (NASDAQ:SHPG)

Analyst Ratings

Consensus Ratings for Shire PLC (NASDAQ:SHPG) (?)
Ratings Breakdown: 2 Hold Rating(s), 23 Buy Rating(s)
Consensus Rating:Buy (Score: 2.92)
Consensus Price Target: $238.29 (24.48% upside)

Analysts' Ratings History for Shire PLC (NASDAQ:SHPG)
Show:
DateFirmActionRatingPrice TargetActions
7/26/2016Shore CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2016Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2016Piper Jaffray Cos.Reiterated RatingNeutral$174.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/12/2016Leerink SwannReiterated RatingBuy$213.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/12/2016BTIG ResearchReiterated RatingBuy$230.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/28/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Royal Bank Of CanadaReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2016Sanford C. BernsteinReiterated RatingOutperform$222.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2016Morgan StanleyReiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Stifel NicolausInitiated CoverageBuy$230.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2016Bryan, Garnier & CoInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2016JPMorgan Chase & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016Liberum CapitalInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2016Bank of America Corp.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Cantor FitzgeraldInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2016Northland SecuritiesReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2016GuggenheimInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/8/2016SusquehannaLower Price TargetPositive$280.00 -> $220.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/18/2016Credit Suisse Group AGUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/18/2016BNP ParibasUpgradeNeutral -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015HSBCUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015William BlairReiterated RatingOutperform$276.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/21/2015Barclays PLCUpgradeEqual Weight -> OverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/16/2015Berenberg BankInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2015Deutsche Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Kepler Capital MarketsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2015S&P Equity ResearchDowngradeStrong-Buy -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015Panmure GordonReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2014CRT CapitalReiterated RatingBuy$225.00 -> $233.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/20/2014SunTrust Banks Inc.UpgradeNeutral -> Buy$269.00 -> $225.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Shire PLC (NASDAQ:SHPG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
4/29/2016Q1$3.05$3.19$1.71 billion$1.71 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2016Q415$2.89$2.97$1.69 million$1.72 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2015Q315$2.87$3.24$1.63 billion$1.58 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015Q215$2.81$2.63$1.59 billion$1.56 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115$2.56$2.84$1.47 billion$1.49 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2015Q115$2.68$2.63$1.58 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2014Q314$2.47$2.93$1.46 billion$1.55 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/18/2014Q214$2.45$2.67$1.45 billion$1.50 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114$2.22$2.36$1.38 billion$1.35 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2014Q413$2.02$2.26$1.28 billion$1.33 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013Q213$1.65$1.77$1.23 billion$1.24 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013$1.60$1.79$1.21 billion$1.28 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q113$1.56$1.63$1.21 billion$1.16 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2013Q412$1.58$1.58$1.20 billion$1.20 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012$1.47$1.36ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2012$1.52$1.68ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012$0.52$1.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2012$0.48$0.44ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2011$1.31$1.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011$1.24$1.33ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011$1.18$1.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2011$1.04$1.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Shire PLC (NASDAQ:SHPG)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20167$2.76$3.17$3.01
Q2 20164$3.05$3.23$3.13
Q3 20164$3.01$3.30$3.15
Q4 20164$3.13$3.68$3.39
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Shire PLC (NASDAQ:SHPG)
Annual Dividend:$0.79
Dividend Yield:0.41%
Payout Ratio:11.90% (Based on Trailing 12 Months of Earnings)
6.35% (Based on Current Year Consensus EPS Estimate)
5.25% (Based on Next Year Consensus EPS Estimate)

Dividend History for Shire PLC (NASDAQ:SHPG)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
2/11/2016$0.673/9/20163/11/20164/12/2016Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015$0.139/2/20159/4/201510/2/2015Tweet This Announcement  Share This Announcement on StockTwits
2/23/2015semiannual$0.570.48%3/11/20153/13/20154/14/2015Tweet This Announcement  Share This Announcement on StockTwits
8/4/2014semiannual$0.110.09%9/3/20149/5/201410/3/2014Tweet This Announcement  Share This Announcement on StockTwits
2/20/2014semiannual$0.510.61%3/5/20143/7/20144/8/2014Tweet This Announcement  Share This Announcement on StockTwits
7/29/2013semiannual$0.090.16%9/4/20139/6/201310/3/2013Tweet This Announcement  Share This Announcement on StockTwits
2/19/2013semiannual$0.440.92%3/6/20133/8/20134/9/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Shire PLC (NASDAQ:SHPG)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Shire PLC (NASDAQ:SHPG)
DateHeadline
07/29/16 09:29 AMShire's SHP626 (Volixibat) Receives FDA Fast Track Designation for an Investigational Treatment for Adults …
07/29/16 09:29 AMShire's (SHPG) SHP626 Granted FDA Fast Track Designation as Investigational Treatment in NASH with Liver Fibrosis
07/29/16 06:18 AMShire’s SHP626 (Volixibat) Receives FDA ... - [at noodls] - July 29, 2016 Lexington, Mass. - July 29, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG)today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for SHP626 ...
07/28/16 08:07 AMWhat to Expect from Shire’s Genetic Disease Franchise -
07/27/16 06:47 PMCan Shares Of Shire plc (NASDAQ:SHPG) Hit $325? - Investor Newswire
07/27/16 10:09 AMHow Will Major Drugs in GI Franchise Perform in 2Q16? -
07/26/16 09:48 AMShire To Present Additional Data On Clinical Experience Of ADYNOVATE
07/25/16 06:33 PMEuropean Ad Comm backs Merrimack and Shire's Onivyde for pancreatic cancer
07/25/16 10:50 AMAccounts Payable For Shire plc (NASDAQ:SHPG) Stood At $1978.2 - RealistInvestor.com
07/25/16 09:34 AMSpecialty Pharma: Earnings Better Be Good…or Else -
07/22/16 06:11 PMAccipiter Capital Management LLC Increased Shire Plc (NASDAQ:SHPG) by $8.27 Million as Shares Declined - Consumer Eagle
07/22/16 06:11 PMGlg Partners LP Increased Shire Plc (Call) (NASDAQ:SHPG) by $13.31 Million as Shares Declined - Consumer Eagle
07/22/16 06:11 PMHC Stocks Analysis: UnitedHealth Group Inc (NYSE:UNH), Shire PLC (ADR) (NASDAQ:SHPG) - share market updates (press release)
07/22/16 09:21 AMAttention Grasping Stock With Upward Momentum: Shire plc (NASDAQ:SHPG) - TGP
07/22/16 09:21 AMToday's Top Gainers in the Market Shire plc (NASDAQ:SHPG) from Healthcare - The Daily Leicester
07/22/16 09:21 AMActive Momentum Stocks- Union Pacific (NYSE:UNP), Shire plc (NASDAQ:SHPG), DR Horton (NYSE:DHI) - Seneca Globe
07/22/16 09:21 AMAnalysts Rating Alert: Biogen Inc. (NASDAQ:BIIB) , Shire plc (NASDAQ:SHPG) - Street Updates
07/22/16 09:21 AMAnalyst Buzz: Shire plc (NASDAQ:SHPG) - News Oracle
07/21/16 06:45 PMChronos Therapeutics takes over three pre-clinical CNS programs from Shire
07/21/16 06:45 PMShire Launches Pediatric Indication For HyQvia In Europe - Quick Facts
07/20/16 07:20 PMIs $325 Price Target Attainable For Shire plc (NASDAQ:SHPG)? - Investor Newswire
07/20/16 07:20 PMShire plc (SHPG) Position Increased by Rockefeller Financial Services Inc - Finance Daily
07/20/16 07:20 PMIs Shire plc(NASDAQ: SHPG), a large market cap stock a smart buy? - The Daily Leicester
07/20/16 09:18 AMShire Plc (NASDAQ:SHPG) Updated Price Targets - FTSE News
07/20/16 09:18 AMHC Stocks Movements: Biogen Inc (NASDAQ:BIIB), Shire PLC (ADR) (NASDAQ:SHPG) - share market updates (press release)
07/19/16 08:52 AMLong Term Value Play: Shire plc (NASDAQ:SHPG) - TGP
07/19/16 08:52 AMStock Pleasing Investors: Shire plc (NASDAQ:SHPG) - TGP
07/19/16 08:52 AMShares of Shire plc (SHPG) Rally 1.69% - Trade Calls
07/19/16 07:30 AM8:30 am Shire plc reinforces commitment in Hematology with robust data presented at international congress of the World Federation of Hemophilia -
07/18/16 02:45 PMShire Plc Ads (NASDAQ:SHPG) Short Interest Decreased By 89.16% - Consumer Eagle
07/18/16 02:45 PMAnalysts Pounding the Table on Shares of Shire plc (NASDAQ:SHPG) - TGP
07/17/16 10:28 AMShire plc (NASDAQ:SHPG) Quarterly Accounts Payable At $1978.2 Millions - RealistInvestor.com
07/15/16 11:38 AMUpdate on Shire plc (NASDAQ:SHPG) for the day - Twin County News
07/15/16 11:38 AMInvestor Catching Stock: Shire plc (NASDAQ:SHPG) - News Oracle
07/15/16 11:38 AMNoticeable Price Moves: Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) , Shire plc (NASDAQ:SHPG) - Street Updates
07/14/16 02:10 PMShire Could Divest ADHD Treatment, Other Assets, for More Upside Post-Baxalta -
07/13/16 09:17 AMShire plc (SHPG): Xiidra is in the Stock - Piper Jaffray - StreetInsider.com
07/12/16 07:44 PMMultimedia assets now available: FDA Approves Shire's Xiidra™ (lifitegrast ophthalmic solution) 5% - The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease - [PR Newswire] - LEXINGTON, Mass., July 12, 2016 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the U.S. Food and Drug Administration (FDA) has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients. Xiidra is the only prescription eye drop indicated for the treatment of both signs and symptoms of this condition. Shire expects to launch Xiidra in the United States in the third quarter of 2016.
07/12/16 06:38 PMShire's (SHPG) Dry Eye Disease Drug Xiidra Gets FDA Nod
07/12/16 10:47 AMSHIRE PLC : - Regulatory Approval
07/12/16 10:47 AMFDA Approves Shire’s Dry-Eye Treatment
07/12/16 10:47 AMFDA OKs Shire’s Xiidra for the treatment of dry eye disease; shares up 5% premarket
07/12/16 10:47 AMShire (SHPG) Announces FDA Approval of Dry Eye Treatment Xiidra
07/12/16 10:47 AMShire Gains Key FDA Approval in Dry Eye Treatment
07/11/16 06:08 PMRegulatory Approval - FDA Approves Shire’s Xiidra™ (lifitegrast ophthalmic solution) 5% – The Only Treatment Indicated for the Signs and Symptoms of Dry Eye Disease - [PR Newswire] - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the U.S. Food and Drug Administration (FDA) has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients. Xiidra is the only prescription eye drop indicated for the treatment of both signs and symptoms of this condition.
07/11/16 11:01 AMSHIRE PLC : - Holding(s) in Company
07/11/16 10:36 AMSHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits -
07/10/16 05:38 PMShire plc (NASDAQ:SHPG) Expected To Post Sales Of $22027.715 - Investor Newswire
07/10/16 05:38 PMHot Stock under Consideration: Shire plc (NASDAQ:SHPG) - News Oracle
07/10/16 05:38 PMShire plc (NASDAQ:SHPG): Check on Company Stock Performance - Press Telegraph

Social

About Shire PLC

Shire PLC logoShire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. The Company focuses its development resources on projects in various therapeutic areas (TAs), including rare diseases, neuroscience, ophthalmics, hematology and gastrointestinal (GI), and focuses its early development projects primarily on rare diseases. Its products include VYVANSE/VENVANSE/ELVANSE/TYVENSE/ELVANSE VUXEN/ADUVANZ, ADDERALL XR, INTUNIV, LIALDA (mesalamine)/MEZAVANT(mesalazine), PENTASA (mesalamine), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant), CINRYZE C1 esterase inhibitor (human), GATTEX/REVESTIVE, NATPARA/NATPAR, FOSRENOL (lanthanum carbonate) and KALBITOR.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SHPG
  • CUSIP:
Key Metrics:
  • Previous Close: $191.43
  • 50 Day Moving Average: $183.55
  • 200 Day Moving Average: $175.84
  • P/E Ratio: 29.01
  • P/E Growth: 0.93
  • Market Cap: $38.07B
  • Beta: 1.06
  • Current Year EPS Consensus Estimate: $12.45 EPS
  • Next Year EPS Consensus Estimate: $15.05 EPS
Additional Links:
Shire PLC (NASDAQ:SHPG) Chart for Friday, July, 29, 2016